There are 2789 resources available
103P - Rate of BRCA1/2 pathogenic variants according to family and personal history of cancer in a large cohort of triple-negative breast cancer (TNBC) patients (pts) younger than 60 years of age
Presenter: Stefania Zovato
Session: ePoster Display
104P - Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
Presenter: Jesus Garcia-Foncillas
Session: ePoster Display
105P - Prognostic value of the NTRK fusion biomarker in the Netherlands
Presenter: Irene Santi
Session: ePoster Display
106P - Prognostic impact of memory CD8(+) T cells on immunotherapy in human cancers: A systematic review and meta-analysis
Presenter: Yao Jin
Session: ePoster Display
107P - Co-mutation of IDH1 and DNA damage repair genes in patients with hepatobiliary cancer implicates longer overall survival
Presenter: Guangming Li
Session: ePoster Display
108P - A comprehensive pan-cancer study of fusions in Chinese cancer patients
Presenter: Mingwei Li
Session: ePoster Display
84P - Metastatic mismatch repair deficiency cancers: Hard to find, but a delight to treat!
Presenter: Amit Rauthan
Session: ePoster Display
110P - Novel genetic variants of CBS and COMT in the transsulfuration pathway genes are associated with survival of non-small cell lung cancer patients
Presenter: Yufeng Wu
Session: ePoster Display
111P - A study on the relationship between tumor fusion burden (TFB) and tumor immune microenvironment
Presenter: xiaoyu Liu
Session: ePoster Display
112P - Prognostic impact of five serum biomarkers in patients with advanced non-small cell lung cancer (NSCLC): An exploratory analysis
Presenter: Yomna Nassar
Session: ePoster Display